Artelo Biosciences, Inc. SEC filings ARTL
Artelo Biosciences, Inc. has 465 filings in SEC EDGAR's recent list, going back to Oct 8, 2014. Its latest annual report, Form ARS, was filed on Jun 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Jun 5, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Feb 24, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Dec 11, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Nov 8, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 25, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | May 16, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 10-KT | Transition report | Mar 21, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Nov 29, 2021 | Aug 31, 2021 |
| 10-K | Annual report | Nov 4, 2020 | Aug 31, 2020 |
| 10-K/A | Amended annual report | Dec 18, 2019 | Aug 31, 2019 |
| 10-K | Annual report | Nov 25, 2019 | Aug 31, 2019 |
| 10-K | Annual report | Nov 29, 2018 | Aug 31, 2018 |
| 10-K | Annual report | Nov 29, 2017 | Aug 31, 2017 |
| 10-K/A | Amended annual report | Dec 1, 2016 | Aug 31, 2016 |
| 10-K | Annual report | Nov 29, 2016 | Aug 31, 2016 |
| 10-K | Annual report | Dec 11, 2015 | Aug 31, 2015 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARTL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Solana Beach, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1621221
- Former names
- REACTIVE MEDICAL INC. (until Apr 17, 2017); KNIGHT KNOX DEVELOPMENT CORP. (until Feb 6, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.